AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
May 052014
 
Rifamycin SV (yellow structure) and GE23077 (blue structure) bind to adjacent sites on RNA polymerase (red and yellow), and a combination of the two is a bacterial resistance-resistant drug lead.

SIDE BY SIDE
Rifamycin SV (yellow stick structure) and GE23077 (blue stick structure) bind to adjacent sites on RNA polymerase (red and green). Mesh indicates electron density; purple ball is active site’s magnesium ion.

Antibiotic May Sidestep Resistance

Drug Discovery: Bacteria may find agent’s mechanism hard to circumvent.

Researchers finally know exactly how the promising antibiotic GE23077 (GE) inhibits an essential bacterial enzyme. They predict that GE’s ability to hit this enzyme in its active site could make it difficult for bacteria to develop resistance to the agent. The study also shows how GE might be conjugated with another antibiotic to make a combination drug the scientists believe might be unusually resistance-proof.

http://cen.acs.org/articles/92/i18/Antibiotic-Sidestep-Resistance.html

Share

  One Response to “Antibiotic May Sidestep Resistance, Drug Discovery: Bacteria may find agent’s mechanism hard to circumvent.”

  1. It looks like a very fundamental break through. Thanks for the info posted

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: